The title compound, C25H18BrN3, crystallizes in the triclinic P1 space group. It is of inter-est with respect to anti-cancer activity, anti-biotic, anti-bacterial and anti-fungal properties. The extended structure features N-H⋯N, C-H⋯N, C-H⋯π, N-H⋯π, C-H... ...
